LPLP
ALXA

Lansdowne Partners Limited Partnership’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Lansdowne Partners Limited Partnership’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-307,500
Closed -$1.33M – 45
2013
Q2 		$1.33M Buy
+307,500
New +$1.39M 0.02% 39

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lansdowne Partners Limited Partnership's ALXA Position: Q3 2013 in Review

Lansdowne Partners Limited Partnership sold out of Alexza Pharmaceuticals Inc (ALXA) in Q3 2013, closing a stake of 307,500 shares — an estimated $1.33M sold.

Lansdowne Partners Limited Partnership first reported a position in ALXA in Q2 2013 and held it in 1 quarter. The position peaked at $1.33M in Q2 2013. 41 funds tracked by Wall St. Rank hold ALXA as of Q3 2013.

  • Lansdowne Partners Limited Partnership reported no remaining Alexza Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • Lansdowne Partners Limited Partnership sold 307,500 Alexza Pharmaceuticals Inc shares in Q3 2013, an estimated $1.33M.
  • Lansdowne Partners Limited Partnership first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • Lansdowne Partners Limited Partnership's Alexza Pharmaceuticals Inc position peaked at $1.33M in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q3 2013.

Based on Lansdowne Partners Limited Partnership's 13F filing for Q3 2013, filed 14 Nov 2013.